The following is a complete and current set of guidance regarding vaccines in the US health care market for the Fall 2024 season. These recommendations are general guidance from the…
Read More
COVID-19 continues to twist and turn as new variants become more predominant. The BQ1 and BQ1.1 variants have become the dominant strains in the US as of mid-November. These variants…
NOTE: This information has been adapted from previous updates and is current as of November 8, 2022. If you haven’t already received your initial COVID-19 vaccination, please get vaccinated as soon as possible. We continue to strongly recommend all individuals receive the COVID-19 vaccination unless you have a known allergy to a component of the vaccine. Below is our current guidance for additional doses and boosters. To see this information in an easy to read, downloadable PDF format, please click here.
The COVID-19 vaccines and boosters remain the best defense against COVID-19. It is very important to receive your vaccine and boosters as soon as possible. Please see our current chart…
NOTE: This information has been adapted from previous updates and is current as of April 11, 2022. Below are answers to some of the frequently asked questions we’ve received recently…
Everything we’ve collectively done over the past year — social distancing, washing hands, staying home, wearing masks — has contributed to the slowdown in infection rates and cases. But the…
The Delta variant of COVID-19 is continuing to spread rapidly and is much more infectious than the original strain of the virus. The single most important step to take to…
Our medical team at the Rocky Mountain MS Center at University of Colorado is recommending that all individuals receive the COVID-19 vaccine, unless there is a specific reason to not…
Our medical team at the Rocky Mountain MS Center at University of Colorado is recommending that all individuals receive the COVID-19 vaccine, unless there is a specific reason to not…
Researchers from the Rocky Mountain MS Center at University of Colorado and New York University are conducting a study to investigate the immune response to the COVID vaccine in multiple…